First Horizon Corporation’s Novo Nordisk NVO Stock Holding History

First Horizon Corporation’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$141K	Buy	2,935 +1,667	+131%	+$71.6K	0.01%	475
2026 Q1	$46.6K	Sell	1,268 -228	-15%	-$10.8K	﹤0.01%	638
2025 Q4	$76.1K	Sell	1,496 -155	-9%	-$7.93K	﹤0.01%	569
2025 Q3	$91.6K	Buy	+1,651	New	+$96.6K	﹤0.01%	505
2021 Q2	$13K	Hold	320	–	–	﹤0.01%	637
2021 Q1	$10K	Sell	320 -26	-8%	-$926	﹤0.01%	685
2020 Q4	$12K	Sell	346 -42	-11%	-$1.45K	﹤0.01%	609
2020 Q3	$13K	Buy	+388	New	+$12.9K	﹤0.01%	566

Other funds holding NVO

EHC

Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

AIIMS

Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

First Horizon Corporation's NVO Position: Q2 2026 in Review

First Horizon Corporation increased its Novo Nordisk (NVO) stake by 131% in Q2 2026, buying an estimated $71.6K and bringing the position to 2,935 shares worth $141K. The position accounts for 0.01% of the portfolio, ranked #475.

First Horizon Corporation first reported a position in NVO in Q3 2020 and has held it in 8 quarters since. 623 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

First Horizon Corporation held 2,935 shares of Novo Nordisk worth $141K as of Q2 2026.
First Horizon Corporation bought 1,667 Novo Nordisk shares in Q2 2026, an estimated $71.6K.
Novo Nordisk made up 0.01% of First Horizon Corporation's portfolio in Q2 2026, its #475 holding.
First Horizon Corporation first reported a position in Novo Nordisk in Q3 2020 and has held it in 8 quarters since.
623 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.